• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于增强放射治疗-放射动力治疗的纳米级卟啉基金属有机框架:综述

Nanoscale Porphyrin-Based Metal-Organic Frameworks for Enhanced Radiotherapy-Radiodynamic Therapy: A Comprehensive Review.

作者信息

Gong Bin, Zhang Qiuyun, Qu Yijie, Zheng Xiaohua, Wang Weiqi

机构信息

The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang 212300, China.

School of Pharmacy, Nantong University, Nantong 226001, China.

出版信息

Pharmaceutics. 2025 Jul 4;17(7):883. doi: 10.3390/pharmaceutics17070883.

DOI:10.3390/pharmaceutics17070883
PMID:40733092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12299130/
Abstract

The phototherapeutic applications of porphyrin-based nanoscale metal-organic frameworks (nMOFs) are limited by the poor penetration of conventional excitation light sources into biological tissues. Radiodynamic therapy (RDT), which directly excites photosensitizers using X-rays, can overcome the issue of tissue penetration. However, RDT faces the problems of low energy conversion efficiency, requiring a relatively high radiation dose, and the potential to cause damage to normal tissues. Researchers have found that by using some metals with high atomic numbers (high Z) as X-ray scintillators and coordinating them with porphyrin photosensitizers to form MOF materials, the excellent antitumor effect of radiotherapy (RT) and RDT can be achieved under low-dose X-ray irradiation, which can not only effectively avoid the penetration limitations of light excitation methods but also eliminate the defect issues associated with directly using X-rays to excite photosensitizers. This review summarizes the relevant research work in recent years, in which researchers have used metal ions with high Z, such as Hf, Th, Ta, and Bi, in coordination with carboxyl porphyrins to form MOF materials for combined RT and RDT toward various cancer cells. This review compares the therapeutic effects and advantages of using different high-Z metals and introduces the application of the heavy atom effect. Furthermore, it explores the introduction of a chemodynamic therapy (CDT) mechanism through iron coordination at the porphyrin center, along with optimization strategies such as oxygen delivery using hemoglobin to enhance the efficacy of these MOFs as radiosensitizers. This review also summarizes the potential of these materials in preclinical applications and highlights the current challenges they face. It is expected that the summary and prospects outlined in this review can further promote preclinical biomedical research into and the development of porphyrin-based nMOFs.

摘要

基于卟啉的纳米级金属有机框架(nMOF)的光治疗应用受到传统激发光源对生物组织穿透性差的限制。放射动力疗法(RDT)直接利用X射线激发光敏剂,可克服组织穿透问题。然而,RDT面临能量转换效率低、需要相对高的辐射剂量以及可能对正常组织造成损伤等问题。研究人员发现,通过使用一些高原子序数(高Z)的金属作为X射线闪烁体,并将它们与卟啉光敏剂配位形成MOF材料,可在低剂量X射线照射下实现放射疗法(RT)和RDT的优异抗肿瘤效果,这不仅能有效避免光激发方法的穿透限制,还能消除直接使用X射线激发光敏剂相关的缺陷问题。本综述总结了近年来的相关研究工作,其中研究人员使用高Z金属离子,如铪、钍、钽和铋,与羧基卟啉配位形成MOF材料,用于对各种癌细胞进行联合RT和RDT。本综述比较了使用不同高Z金属的治疗效果和优势,并介绍了重原子效应的应用。此外,还探讨了通过在卟啉中心进行铁配位引入化学动力疗法(CDT)机制,以及诸如使用血红蛋白进行氧气输送等优化策略,以提高这些MOF作为放射增敏剂的疗效。本综述还总结了这些材料在临床前应用中的潜力,并突出了它们目前面临的挑战。预计本综述中的总结和展望能够进一步推动基于卟啉的nMOF的临床前生物医学研究和开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/0367863c75cb/pharmaceutics-17-00883-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/472b59e0bb67/pharmaceutics-17-00883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/d6fa87014290/pharmaceutics-17-00883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/c3d29018bb21/pharmaceutics-17-00883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/4cadebce425c/pharmaceutics-17-00883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/9a300868bb49/pharmaceutics-17-00883-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/2e4567d66336/pharmaceutics-17-00883-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/fd664d74f1e1/pharmaceutics-17-00883-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/b9172e4acf00/pharmaceutics-17-00883-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/21c3d52b5e30/pharmaceutics-17-00883-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/2ae4b872b2d6/pharmaceutics-17-00883-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/0367863c75cb/pharmaceutics-17-00883-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/472b59e0bb67/pharmaceutics-17-00883-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/d6fa87014290/pharmaceutics-17-00883-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/c3d29018bb21/pharmaceutics-17-00883-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/4cadebce425c/pharmaceutics-17-00883-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/9a300868bb49/pharmaceutics-17-00883-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/2e4567d66336/pharmaceutics-17-00883-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/fd664d74f1e1/pharmaceutics-17-00883-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/b9172e4acf00/pharmaceutics-17-00883-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/21c3d52b5e30/pharmaceutics-17-00883-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/2ae4b872b2d6/pharmaceutics-17-00883-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d9f/12299130/0367863c75cb/pharmaceutics-17-00883-g011.jpg

相似文献

1
Nanoscale Porphyrin-Based Metal-Organic Frameworks for Enhanced Radiotherapy-Radiodynamic Therapy: A Comprehensive Review.用于增强放射治疗-放射动力治疗的纳米级卟啉基金属有机框架:综述
Pharmaceutics. 2025 Jul 4;17(7):883. doi: 10.3390/pharmaceutics17070883.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Short-Term Memory Impairment短期记忆障碍
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.

本文引用的文献

1
Evolution of nMOFs in photodynamic therapy: from porphyrins to chlorins and bacteriochlorins for better efficacy.用于光动力疗法的纳米金属有机框架的演变:从卟啉到二氢卟酚和细菌叶绿素以提高疗效
Front Pharmacol. 2025 Mar 18;16:1533040. doi: 10.3389/fphar.2025.1533040. eCollection 2025.
2
Recent Advances in Glutathione Depletion-Enhanced Porphyrin-Based nMOFs for Photodynamic Therapy.用于光动力疗法的谷胱甘肽消耗增强型卟啉基纳米金属有机框架的最新进展
Pharmaceutics. 2025 Feb 12;17(2):244. doi: 10.3390/pharmaceutics17020244.
3
A reactive oxygen species amplifier based on a BiWO/BP heterojunction for high efficiency radiotherapy enhancement.
基于BiWO/BP异质结的用于高效放疗增强的活性氧物种放大器
J Mater Chem B. 2025 Feb 26;13(9):3128-3137. doi: 10.1039/d4tb02285h.
4
Recent Advances in Porphyrin-Based Covalent Organic Frameworks for Synergistic Photodynamic and Photothermal Therapy.基于卟啉的共价有机框架用于协同光动力和光热治疗的最新进展
Pharmaceutics. 2024 Dec 22;16(12):1625. doi: 10.3390/pharmaceutics16121625.
5
Synthesis and Evaluation of a Bifunctional Chelator for Thorium-227 Targeted Radiotherapy.用于钍-227靶向放射治疗的双功能螯合剂的合成与评价
J Med Chem. 2025 Jan 23;68(2):1682-1692. doi: 10.1021/acs.jmedchem.4c02423. Epub 2025 Jan 3.
6
X-ray-activated nanoscintillators integrated with tumor-associated neutrophils polarization for improved radiotherapy in metastatic colorectal cancer.集成肿瘤相关中性粒细胞极化的X射线激活纳米闪烁体用于改善转移性结直肠癌的放射治疗
Biomaterials. 2025 May;316:123031. doi: 10.1016/j.biomaterials.2024.123031. Epub 2024 Dec 16.
7
Recent advances in cell membrane-coated porphyrin-based nanoscale MOFs for enhanced photodynamic therapy.用于增强光动力疗法的细胞膜包被的卟啉基纳米级金属有机框架的最新进展
Front Pharmacol. 2024 Dec 4;15:1505212. doi: 10.3389/fphar.2024.1505212. eCollection 2024.
8
Enhancing Chordoma Radiotherapy: Ta@PVP Nanoparticles as Potent Radiosensitizers.增强脊索瘤放疗效果:Ta@PVP纳米颗粒作为强效放射增敏剂
ACS Appl Mater Interfaces. 2025 Jan 8;17(1):750-762. doi: 10.1021/acsami.4c19601. Epub 2024 Dec 18.
9
Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of indoleamine 2,3-dioxygenase 1.新型分子作为吲哚胺2,3-双加氧酶1强效抑制剂的设计、合成及生物学评价
Mol Divers. 2024 Nov 23. doi: 10.1007/s11030-024-11043-z.
10
Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.用于X射线刺激癌症治疗的纳米级混合配体金属有机框架
J Am Chem Soc. 2024 Dec 4;146(48):33149-33158. doi: 10.1021/jacs.4c12140. Epub 2024 Nov 20.